Innovative treatments for exudative age-related macular degenerationKIM, Rubin W; HEIER, Jeffrey S.International ophthalmology clinics. 2004, Vol 44, Num 4, pp 41-50, issn 0020-8167, 10 p.Article

Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degenerationROSENFELD, Philip J; HEIER, Jeffrey S; HANTSBARGER, Gary et al.Ophthalmology (Rochester, MN). 2006, Vol 113, Num 4, pp 623-632, issn 0161-6420, 10 p.Article

Primary Endpoint Results of a Phase II Study of Vascular Endothelial Growth Factor Trap-Eye in Wet Age-related Macular DegenerationBROWN, David M; HEIER, Jeffrey S; KE YANG et al.Ophthalmology (Rochester, MN). 2011, Vol 118, Num 6, pp 1089-1097, issn 0161-6420, 9 p.Article

Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration : 1-year resultsHUDSON, Henry L; LANE, Stephen S; HEIER, Jeffrey S et al.Ophthalmology (Rochester, MN). 2006, Vol 113, Num 11, pp 1987-2001, issn 0161-6420, 15 p.Article

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration : Year 1 results of the FOCUS studyHEIER, Jeffrey S; BOYER, David S; CIULLA, Thomas A et al.Archives of ophthalmology (1960). 2006, Vol 124, Num 11, pp 1532-1542, issn 0003-9950, 11 p.Article

Multiple laser treatments for macular edema attributable to branch retinal vein occlusionESRICK, Erica; SUBRAMANIAN, Manju L; HEIER, Jeffrey S et al.American journal of ophthalmology. 2005, Vol 139, Num 4, pp 653-657, issn 0002-9394, 5 p.Article

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular DegenerationHEIER, Jeffrey S; BROWN, David M; STAHL, Neil et al.Ophthalmology (Rochester, MN). 2012, Vol 119, Num 12, pp 2537-2548, issn 0161-6420, 12 p.Article

Implantable Telescope for End-Stage Age-related Macular Degeneration : Long-term Visual Acuity and Safety OutcomesHUDSON, Henry L; STULTING, R. Doyle; HEIER, Jeffrey S et al.American journal of ophthalmology. 2008, Vol 146, Num 5, pp 664-673, issn 0002-9394, 10 p.Article

A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edemaCHUN, Dal W; HEIER, Jeffrey S; TOPPING, Trexler M et al.Ophthalmology (Rochester, MN). 2006, Vol 113, Num 10, pp 1706-1712, issn 0161-6420, 7 p.Article

Ranibizumab for neovascular age-related macular degenerationROSENFELD, Philip J; BROWN, David M; HEIER, Jeffrey S et al.The New England journal of medicine. 2006, Vol 355, Num 14, pp 1419-1431, issn 0028-4793, 13 p.Article

Ranibizumab versus verteporfin for neovascular age-related macular degenerationBROWN, David M; KAISER, Peter K; MICHELS, Mark et al.The New England journal of medicine. 2006, Vol 355, Num 14, pp 1432-1444, issn 0028-4793, 13 p.Article

Detection of New-Onset Choroidal Neovascularization Using Optical Coherence Tomography: The AMD DOC StudyDO, Diana V; GOWER, Emily W; CASSARD, Sandra D et al.Ophthalmology (Rochester, MN). 2012, Vol 119, Num 4, pp 771-778, issn 0161-6420, 8 p.Article

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Long-term Follow-up in the HORIZON TrialHEIER, Jeffrey S; CAMPOCHIARO, Peter A; YAU, Linda et al.Ophthalmology (Rochester, MN). 2012, Vol 119, Num 4, pp 802-809, issn 0161-6420, 8 p.Article

Pseudoexfoliation: High risk factors for zonule weakness and concurrent vitrectomy during phacoemulsificationSHINGLETON, Bradford J; MARVIN, Alicia C; HEIER, Jeffrey S et al.Journal of cataract and refractive surgery. 2010, Vol 36, Num 8, pp 1261-1269, issn 0886-3350, 9 p.Article

A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular DegenerationBOYER, David S; HEIER, Jeffrey S; BROWN, David M et al.Ophthalmology (Rochester, MN). 2009, Vol 116, Num 9, pp 1731-1739, issn 0161-6420, 9 p.Conference Paper

Ranibizumab for treatment of neovascular age-related macular degeneration : A phase I/II multicenter, controlled, multidose studyHEIER, Jeffrey S; ANTOSZYK, Andrew N; SHAMS, Naveed et al.Ophthalmology (Rochester, MN). 2006, Vol 113, Num 4, pp 633-642, issn 0161-6420, 10 p.Article

Ranibizumab for Choroidal Neovascularization Secondary to Causes Other Than Age-Related Macular Degeneration: A Phase I Clinical TrialHEIER, Jeffrey S; BROWN, David; CIULLA, Thomas et al.Ophthalmology (Rochester, MN). 2011, Vol 118, Num 1, pp 111-118, issn 0161-6420, 8 p.Article

The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed DosingHEIER, Jeffrey S; BOYER, David; KE YANG et al.Ophthalmology (Rochester, MN). 2011, Vol 118, Num 6, pp 1098-1106, issn 0161-6420, 9 p.Article

Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion: Six-Month Primary End Point Results of a Phase III StudyCAMPOCHIARO, Peter A; HEIER, Jeffrey S; FEINER, Leonard et al.Ophthalmology (Rochester, MN). 2010, Vol 117, Num 6, pp 1102-1112, issn 0161-6420, 11 p.Article

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration : Two-Year Results of the ANCHOR StudyBROWN, David M; MICHELS, Mark; KAISER, Peter K et al.Ophthalmology (Rochester, MN). 2009, Vol 116, Num 1, pp 57-65, issn 0161-6420, 9 p.Article

Ketorolac versus prednisolone versus combination therapy in the Treatment of acute pseudophakic cystoid macular edema. DiscussionHEIER, Jeffrey S; TOPPING, Trexler M; BAUMANN, Wendall et al.Ophthalmology (Rochester, MN). 2000, Vol 107, Num 11, pp 2034-2039, issn 0161-6420Article